Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Brigham and Women's Hospital AstraZeneca |
---|---|
Information provided by: | Brigham and Women's Hospital |
ClinicalTrials.gov Identifier: | NCT00413309 |
To determine the rate of symptomatic and asymptomatic gastrointestinal erosions and ulcerations in patients on dual antiplatelet (aspirin and clopidogrel) therapy after percutaneous coronary intervention (PCI).
Condition | Intervention |
---|---|
Acute Coronary Syndrome |
Procedure: Video Capsule Endoscopy |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention |
Estimated Enrollment: | 30 |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Brigham and Women's Hospital | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Samuel Z. Goldhaber, MD | Brigham and Women's Hospital |
Responsible Party: | Brigham and Women's Hospital ( Samuel Z. Goldhaber, MD ) |
Study ID Numbers: | 2006-P-000376 |
Study First Received: | December 15, 2006 |
Last Updated: | May 1, 2008 |
ClinicalTrials.gov Identifier: | NCT00413309 |
Health Authority: | United States: Institutional Review Board |
Acute Coronary Syndrome Percutaneous Coronary Intervention Antiplatelet Therapy PillCam Endoscopy |
Heart Diseases Aspirin Clopidogrel Myocardial Ischemia |
Ulcer Acute Coronary Syndrome Vascular Diseases Ischemia |
Pathologic Processes Disease Syndrome Cardiovascular Diseases |